Patients with a prescription for opioids would temporarily qualify for the state’s medical marijuana program under a bill the Illinois Senate passed Thursday.
Supporters say the idea is to give those in pain alternatives amid the ongoing opioid addiction epidemic. Opponents suggested the bill is an effort to help Illinois’ new medical marijuana dispensaries make money.
Under the proposal, patients would be allowed to take an opioid prescription and a signed doctor’s note into a marijuana dispensary and buy pot instead. The dispensary must verify approval from a doctor and ensure a patient is not already receiving medical marijuana through another means.
Patients then would receive a 12-month temporary card to buy medical marijuana, restricted to the current limit of no more than 2.5 ounces of cannabis during a two-week period. At the end of a year, a patient could apply for a more permanent medical marijuana card should his or her condition persist.
Sponsoring state Sen. Don Harmon, D-Oak Park, called opioid addiction “a crisis ravaging the state” and said the bill “keeps people from getting strung out and spiraling down.” [Read more at Chicago Tribune]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
Watching Santa Ana, California-based Unrivaled Brands (OTCQX: UNRV) compete in this market reminds me of the movie Memento, where memoryless Guy Pearce literally experiences the action unfold along with the rest of us, even though it’s his story and he’s the only one in it living life essentially in reverse. Similarly, and this may indeed…
LOS ANGELES (AP) — The U.S.′ expanding legal marijuana market is helping drive strong sales and profit growth for multistate operators like Trulieve Cannabis Corp. The Quincy, Florida-based company sells cannabis products in 11 states from Arizona to Pennsylvania. It reported $408.9 million in revenue in the first half of this year, an 89% jump…
A new research report from New Frontier Data, Cannabis and Wellness, a New Consumer Paradigm, challenges the existing framework of the cannabis market and expands it from a two-segment medical and adult-use (recreational) market to a three-segment market. In keeping with changing consumer perceptions and lessening social stigmas related to cannabis across age groups, the…
In a sign that Europe’s cannabis market is gaining traction, the Frankfurt-based operator of a website that pairs patients with marijuana-prescribing doctors has closed a seed funding round while adding one of the industry’s biggest-name executives to its board. The Bloomwell Group, a holding company for the marijuana telemedicine platform Algea Care, obtained more than…